01—History
EPS (Diluted) History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2019–FY2025. Drag across the bars to change the range.
- $11.03
1 older move runs past ±150% (largest +1093.6%); point at, tap or drag across the bars to read one.
02—Ledger
EPS (Diluted), period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $11.03 | +90.5% | 10-K | |
| FY2024 | $5.79 | −57.8% | 10-K | |
| FY2023 | $13.72 | +75.7% | 10-K | |
| FY2022 | $7.81 | +41.7% | 10-K | |
| FY2021 | $5.51 | −2.1% | 10-K | |
| FY2019 | $5.63 | +0.4% | 10-K | |
| FY2018 | $5.61 | +1093.6% | 10-K | |
| FY2017 | $0.47 | −91.4% | 10-K | |
| FY2016 | $5.48 | −3.9% | 10-K | |
| FY2014 | $5.70 | +18.5% | 10-K | |
| FY2013 | $4.81 | +24.6% | 10-K | |
| FY2012 | $3.86 | −19.2% | 10-K | |
| FY2011 | $4.78 | +8.6% | 10-K | |
| FY2010 | $4.40 | −3.7% | 10-K | |
| FY2008 | $4.57 | +25.9% | 10-K | |
| FY2007 | $3.63 | — | 10-K |
03—Questions
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is JOHNSON & JOHNSON's current eps (diluted)?
JOHNSON & JOHNSON (JNJ) annual eps (diluted) for 2025 was $11.03, a 90.50% increase from 2024. JOHNSON & JOHNSON eps (diluted) for the quarter ending June 28, 2026 was $2.27.
What was JOHNSON & JOHNSON's eps (diluted) in 2024?
JOHNSON & JOHNSON annual eps (diluted) for 2024 was $5.79, a 57.80% decline from 2023.
What was JOHNSON & JOHNSON's eps (diluted) in 2023?
JOHNSON & JOHNSON annual eps (diluted) for 2023 was $13.72, a 75.67% increase from 2022.
What is JOHNSON & JOHNSON's 4-year eps (diluted) CAGR?
JOHNSON & JOHNSON eps (diluted) grew at a compound annual growth rate (CAGR) of 18.95% from FY2021 to FY2025, going from $5.51 to $11.03 over 4 years.
- Company
- JOHNSON & JOHNSON
- Ticker
- JNJ
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations